377538 The Influence of Peristalsis Enhanced Permeability on Drug Delivery in the Gastrointestinal Tract

Wednesday, November 19, 2014: 1:24 PM
214 (Hilton Atlanta)
Leonard F. Pease III, Chemical Engineering, Internal Medicine (Gastroenterology), and Pharmaceutics & Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT

Here we evaluate the influence of peristalsis on delivery of pharmaceutical agents into the esophagus.  Although drug delivery to the esophagus remains challenging (bolus passage completes in <20 s), it is increasingly important.  For example, debilitating esophageal diseases including eosinophilic esophagitis (EoE) require delivery of small molecules such as the glucocorticoids fluticasone and budesonide to the lumenal surface of the esophageal.  These molecules counter damage to the mucosal surface caused by the invasion of eosinophils, a type of white blood cell, into the esophagus.  Yet, how esophageal peristalsis affects drug delivery remains unclear.  For example, we know experimentally that as the bolus moves from the oral cavity to the stomach, the esophageal wall moves in the opposite direction (towards the oral cavity) introducing both a tensile strain on the esophageal wall and retrograde surface velocities.  This talk will discuss each of these effects and their influence on the rate of small molecule transport through the mucus and tissue.

Extended Abstract: File Not Uploaded
See more of this Session: Modeling Approaches in the Life Sciences
See more of this Group/Topical: Topical Conference: Systems Biology